idemia with statins
reduces the likelihood of adverse cardiovascular events in
patients with atherosclerosis.56,68-70 Patients with PAD
were designated as high or very high risk for adverse cardiovascular events by the National Cholesterol Educational
Program Adult Treatment Panel #3 and are advised to
undergo treatment to lower low-density lipoprotein
cholesterol to <100 mg/dL or to <70 mg/dL in very
high-risk